We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.8M
AUM Growth
-$80M
(-55%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-199.18%
Top 10 Holdings %
Top 10 Hldgs %
49.58%
Holding
538
New
154
Increased
37
Reduced
174
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$7.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$888K |
| 3 |
Morgan Stanley
MS
|
+$644K |
| 4 |
Eli Lilly
LLY
|
+$522K |
| 5 |
Franklin Resources
BEN
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$18.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$8.78M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.64M |
| 4 |
Merck
MRK
|
+$637K |
| 5 |
CNX Resources
CNX
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.05% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 5.98% |
| 4 | Real Estate | 5.72% |
| 5 | Consumer Discretionary | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WRK
176
DELISTED
WestRock Company
WRK
| $44K | 0.07% |
+764
| New | +$46.9K |
|
177
Conduent
CNDT
$226M
| $41K | 0.06% |
+2,254
| New | +$43.5K |
|
178
Idexx Laboratories
IDXX
$42.5B
| $41K | 0.06% |
186
-871
| -82% | -$179K |
|
179
PUT
Tyson Foods
TSN
$20B
| $40K | 0.06% |
+10,000
| New | +$695K |
|
180
Adobe
ADBE
$84.3B
| $39K | 0.06% |
+158
| New | +$37.4K |
|
181
Booking.com
BKNG
$134B
| $39K | 0.06% |
+475
| New | +$40K |
|
182
Illumina
ILMN
$29.8B
| $39K | 0.06% |
+142
| New | +$36.1K |
|
183
Intuit
INTU
$77B
| $39K | 0.06% |
190
-977
| -84% | -$187K |
|
184
MDU Resources
MDU
$4.42B
| $39K | 0.06% |
3,603
-17,594
| -83% | -$188K |
|
185
PayPal
PYPL
$49.4B
| $39K | 0.06% |
464
-2,195
| -83% | -$175K |
|
186
Royal Gold
RGLD
$16.9B
| $39K | 0.06% |
+416
| New | +$37.2K |
|
187
SiriusXM
SIRI
$10.1B
| $39K | 0.06% |
572
-2,676
| -82% | -$181K |
|
188
T. Rowe Price
TROW
$24.6B
| $39K | 0.06% |
334
-1,525
| -82% | -$177K |
|
189
Wells Fargo
WFC
$261B
| $39K | 0.06% |
+699
| New | +$37.4K |
|
190
Analog Devices
ADI
$185B
| $38K | 0.06% |
+391
| New | +$36.9K |
|
191
Automatic Data Processing
ADP
$97.1B
| $38K | 0.06% |
281
-1,547
| -85% | -$196K |
|
|
ANSS
192
DELISTED
Ansys
ANSS
| $38K | 0.06% |
218
-2,944
| -93% | -$490K |
|
193
Aon
AON
$76B
| $38K | 0.06% |
278
-2,989
| -91% | -$421K |
|
194
Bunge Global
BG
$23.7B
| $38K | 0.06% |
+539
| New | +$38.6K |
|
195
Brown & Brown
BRO
$22.3B
| $38K | 0.06% |
1,362
-11,058
| -89% | -$301K |
|
196
BWX Technologies
BWXT
$16.2B
| $38K | 0.06% |
+605
| New | +$40.2K |
|
197
Cadence Design Systems
CDNS
$91.1B
| $38K | 0.06% |
866
-6,626
| -88% | -$272K |
|
198
Colgate-Palmolive
CL
$72.1B
| $38K | 0.06% |
+580
| New | +$37.9K |
|
199
Chipotle Mexican Grill
CMG
$41.1B
| $38K | 0.06% |
+4,350
| New | +$35.6K |
|
200
Salesforce
CRM
$129B
| $38K | 0.06% |
281
-822
| -75% | -$105K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q2 2018 Portfolio in Review
As of Q2 2018, TLP Group held 538 positions worth $65.8M, down 55% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
TLP Group withdrew a net $131M in Q2 2018, closing 157 positions and reducing 174 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $18.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
Against the trend, TLP Group opened a new position in Franklin Resources worth $352K.
- TLP Group's largest Q2 2018 buy was Franklin Resources: 10,992 shares worth $352K.
- TLP Group added most to iShares Russell 2000 ETF in Q2 2018, an estimated $7.91M increase.
- TLP Group's biggest Q2 2018 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $8.78M.
- TLP Group fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $18.5M.
- TLP Group's ten largest holdings make up 50% of its $65.8M portfolio in Q2 2018.
- TLP Group opened 154 new positions and closed 157 in Q2 2018.
- TLP Group's portfolio value fell 55% quarter-over-quarter to $65.8M.
Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.